**Core Concept**
Beryllium exposure refers to the inhalation of beryllium dust or fumes, which can cause a severe lung disease known as berylliosis or chronic beryllium disease (CBD). This condition is characterized by granulomatous inflammation in the lung parenchyma, leading to progressive pulmonary fibrosis and respiratory failure.

**Why the Correct Answer is Right**
The pathogenesis of CBD involves the sensitization of T-lymphocytes to beryllium antigens, which triggers a cell-mediated immune response. This response leads to the activation of alveolar macrophages, resulting in the release of pro-inflammatory cytokines and the recruitment of lymphocytes to the lung tissue. The subsequent granulomatous inflammation and fibrosis are thought to be mediated by the cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha).

**Why Each Wrong Option is Incorrect**
**Option A:** Beryllium exposure is not primarily associated with renal damage. While some heavy metals, like mercury and cadmium, are nephrotoxic, beryllium's primary effect is on the lungs.
**Option B:** Beryllium exposure is not typically associated with neurotoxicity or peripheral neuropathy. Although some metals, like arsenic and lead, can cause neurological symptoms, beryllium's primary effects are respiratory.
**Option C:** Beryllium exposure is not directly linked to cancer, although long-term exposure to certain carcinogens can increase cancer risk. Beryllium's primary concern is its pulmonary effects.

**Clinical Pearl / High-Yield Fact**
The beryllium lymphocyte proliferation test (BeLPT) is a diagnostic tool used to assess the immune response to beryllium antigens in individuals exposed to beryllium dust or fumes. A positive test result indicates sensitization to beryllium and an increased risk of developing CBD.

**Correct Answer:** D.